சுரேஷ் ஜாதவ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from சுரேஷ் ஜாதவ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In சுரேஷ் ஜாதவ் Today - Breaking & Trending Today

Adar Poonawala is the only official spokesperson, clarifies SII after executive director criticises Centre over COVID vaccination


Serum Institute of India CEO Adar Poonawalla. [Photo/ANI]
Adar Poonawala is the only official spokesperson, clarifies SII after executive director criticises Centre over COVID vaccination
ANI |
Updated: May 23, 2021 22:30 IST
By Shalini Bhardwaj
New Delhi [India], May 23 (ANI): Two days after Serum Institute of India (SII) executive director Suresh Jadhav s controversial remarks on India s vaccination drive against COVID-19, the world s largest vaccine maker completely dissociated itself from the statement and clarified that CEO Adar Poonawalla is the only official spokesperson of the company.
He isn t authorised to speak on these issues only the official spokesperson of the company is allowed to speak, SII CEO Adar Poonawalla told ANI. ....

New Delhi , Prakash Kumar Singh , Shalini Bhardwaj , Adar Poonawalla , Suresh Jadhav , Union Health Ministry , Regulatory Affairs , Serum Institute Of India , Serum Institute Of India Private , World Health Organisation , Serum Institute , India Private Limited , Official Spokesperson , Adar Poonawala , Covid Vaccination , Union Health Ministry , புதியது டெல்ஹி , பிரகாஷ் குமார் சிங் , அடார் பூனாவல்ல , சுரேஷ் ஜாதவ் , தொழிற்சங்கம் ஆரோக்கியம் அமைச்சகம் , ஒழுங்குமுறை வாழ்க்கைத்தொழில்கள் , சீரம் நிறுவனம் ஆஃப் இந்தியா , சீரம் நிறுவனம் ஆஃப் இந்தியா ப்ரைவேட் , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , சீரம் நிறுவனம் ,

Vacciine drive: SII distances itself from statement of executive director | India News


NEW DELHI: The Serum Institute has dissociated itself from its executive director’s statement that the government began the Covid-19 vaccination of multiple age groups without taking into consideration the available stock, stating that this is “not the view of the company”.
In a letter to the health ministry on May 22, Prakash Kumar Singh, director of government and regulatory affairs at the Pune-based Serum Institute of India (SII), clarified that the statement by its executive director Suresh Jadav at a recent event is not the view of the company, sources said.
“On behalf of our CEO Adar C Poonawalla, I want to inform you that this statement is not issued on behalf of SIIPL (Serum Institute of India Pvt Ltd) and the company completely dissociates itself from this statement. this is not the view of the company at all. ....

Prakash Kumar Singh , Adarc Poonawalla , Suresh Jadav , Serum Institute Of India Pvt Ltd , Serum Institute , Serum Institute Of India , Pune Based Serum Institute , India Pvt Ltd , Suresh Jadhav , Ndia News , Ndia News Today , Oday News , Google News , Reaking News , பிரகாஷ் குமார் சிங் , சுரேஷ் ஜாதவ் , சீரம் நிறுவனம் ஆஃப் இந்தியா பிரைவேட் லிமிடெட் , சீரம் நிறுவனம் , சீரம் நிறுவனம் ஆஃப் இந்தியா , புனே அடிப்படையிலானது சீரம் நிறுவனம் , இந்தியா பிரைவேட் லிமிடெட் ,